NCT06107920View on ClinicalTrials.gov

Neoadjuvant Chemotherapy for Obstructive Colon cancER First Treated by cOlostomy

PHASE3Not yet recruitingINTERVENTIONAL

Enrollment

232

Participants

Timeline

Start Date

January 31, 2025

Primary Completion Date

January 31, 2032

Study Completion Date

January 31, 2032

Conditions

Colon Cancer

Interventions

DRUG

Neoadjuvant chemotherapy

Diverting stoma- neoadjuvant chemotherapy - colectomy - +/- adjuvant chemotherapy

All Listed Sponsors

lead

University Hospital, Rouen

OTHER